Total Liabilities (Quarterly) Chart

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 28.94M
March 31, 2026 28.62M
December 31, 2025 30.80M
September 30, 2025 31.58M
June 30, 2025 33.78M
March 31, 2025 34.73M
December 31, 2024 39.36M
September 30, 2024 40.47M
June 30, 2024 38.96M
March 31, 2024 38.22M
December 31, 2023 41.83M
September 30, 2023 38.06M
June 30, 2023 37.68M
March 31, 2023 37.39M
December 31, 2022 40.56M
September 30, 2022 47.18M
Date Value
June 30, 2022 46.46M
March 31, 2022 46.92M
December 31, 2021 51.78M
September 30, 2021 55.18M
June 30, 2021 36.86M
March 31, 2021 32.51M
December 31, 2020 21.91M
September 30, 2020 19.09M
June 30, 2020 6.325M
March 31, 2020 7.539M
December 31, 2019 205.45M
September 30, 2019 120.53M
June 30, 2019 0.00
March 31, 2019
December 31, 2018 67.37M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

View Total Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Liabilities (Quarterly) Benchmarks

View Total Liabilities (Quarterly) Benchmarks
Start Trial
Agenus, Inc. 378.54M
Amgen, Inc. 83.95B
BioCryst Pharmaceuticals, Inc. 1.012B
Imunon, Inc. 10.80M
Curis, Inc. 14.28M

Total Liabilities (Quarterly) Related Metrics